Citations are updated once a week. Recently added citations may not appear.
Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies.
Scientific reports (Sci Rep ) Vol: 11 Issue 1 Pages: 7113
Pub: 2021 Mar 29 Epub: 2021 Mar 29 Authors Laserna-Mendieta EJ , FitzGerald JA , Arias-Gonzalez L , Ollala JM , Bernardo D , Claesson MJ , Lucendo AJ ,
Esophageal microbiome in eosinophilic esophagitis.
PloS one (PLoS One ) Vol: 10 Issue 5 Pages: e0128346
Pub: 2015 Epub: 2015 May 28 Authors Harris JK , Fang R , Wagner BD , Choe HN , Kelly CJ , Schroeder S , Moore W , Stevens MJ , Yeckes A , Amsden K , Kagalwalla AF , Zalewski A , Hirano I , Gonsalves N , Henry LN , Masterson JC , Robertson CE , Leung DY , Pace NR , Ackerman SJ , Furuta GT , Fillon SA ,
Inflammation-associated microbiota in pediatric eosinophilic esophagitis.
Microbiome (Microbiome ) Vol: 3 Issue Pages: 23
Pub: 2015 Epub: 2015 Jun 1 Authors Benitez AJ , Hoffmann C , Muir AB , Dods KK , Spergel JM , Bushman FD , Wang ML ,
A decreased abundance of clostridia characterizes the gut microbiota in eosinophilic esophagitis.
Physiological reports (Physiol Rep ) Vol: 7 Issue 20 Pages: e14261
Pub: 2019 Oct Epub: Authors Kashyap PC , Johnson S , Geno DM , Lekatz HR , Lavey C , Alexander JA , Chen J , Katzka DA ,
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC , DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.